BUZZ - Citi raises profit forecasts for Australia’s EVT after the company issues a positive first-quarter earnings update
路透社2026/10/25 21:00October 25 - ** Citi raised its FY2027 net profit forecast for EVT Ltd EVT.AX by 14%, and also increased its forecasts for FY2028 and FY2029 by 2% each, after the company released a positive FY2027 Q1 performance update
** The entertainment and tourism company announced on Friday (link) that group EBITDA for FY2027 Q1 was 72.5 million Australian dollars, representing a 17% year-on-year increase on a normalized basis
** Citi said the company's entertainment segment Q1 EBITDA grew by 171%, far exceeding Visible Alpha's FY27 H1 consensus forecast of 41%
** Citi noted that although the EVT hotels division is expected to increase EBITDA by about 13 million Australian dollars in FY2027, its Q1 earnings were essentially flat, which was somewhat disappointing
** Citi added that asset disposals remain challenging, as rising interest rates, high construction costs, and continued weakness in property prices are putting pressure on the sale outlook for the 525 George Street property
** All five analysts rate the stock as “Buy” or higher; the median price target is 16.55 AUD—LSEG data
** As of the last trading day's close, the stock has gained 20.6% so far this year
(To facilitate non-native English speakers, Reuters has automatically translated its report into several other languages. Since automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the automated translation text and provides it solely as a convenience for readers. Reuters assumes no responsibility for any damage or loss caused by the use of automated translation services.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Survival period doubled! AstraZeneca's new stomach cancer drug Sone-ve aims for $5 billion in annual sales, ADC takes another step towards replacing chemotherapy
AstraZeneca's gastric cancer ADC doubles patient survival, extending life by five more months, aiming for annual sales of $5 billion; the company is racing with Takeda and Astellas to target Claudin 18.2.
16 trillion Korean won "big dividend"! SK hynix (SKHY.US) plans to distribute 80% of Kioxia stake earnings generously to shareholders
According to reports, SK Hynix plans to return about 80% of the proceeds from reducing its stake in Japan's Kioxia Holdings to shareholders by distributing a special dividend of approximately 16 trillion won (about $12 billion).
Korean retail investors start bottom fishing! Their targets are still "Samsung and SK Hynix leveraged ETFs"
Amid a sharp drop in Korean stocks, Korean retail investors turned contrarian, making a net purchase of over 315.4 billion KRW in leveraged products of Samsung and SK Hynix in October alone. They simultaneously spent 4.7 trillion KRW acquiring US-listed triple-leveraged semiconductor ETF (SOXL), accounting for nearly 74% of total purchases of US stocks during the same period. This marks the first rebound since tightening regulations in July and two consecutive months of net selling.

AI Bubble Index at 74, CoreWeave (CRWV.US) stock price may fall below $50
CoreWeave's stock price has dropped nearly 70% from its peak to $54.25, with the short interest ratio rising to 15%. As the AI bubble index reaches an extreme value of 74 and the company faces $3 billion in debt pressure, its share price is at risk of falling below the critical support level of $50.
